We are live on ! Find out more
CF

Cantor Fitzgerald Portfolio holdings

AUM $6.78B
1-Year Est. Return 29.01%
This Fund
S&P 500
This Quarter Est. Return
+7.12%
1 Year Est. Return
+29.01%
3 Year Est. Return
+173.81%
5 Year Est. Return
10 Year Est. Return
AUM
$4.65B
AUM Growth
+$73.5M
Cap. Flow
+$759M
Cap. Flow %
16.3%
Top 10 Hldgs %
13.94%
Holding
934
New
146
Increased
191
Reduced
181
Closed
213

Sector Composition

Rank Sector Weight
1 Financials 28.53%
2 Technology 14.53%
3 Healthcare 10.47%
4 Industrials 7.31%
5 Consumer Discretionary 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADBE icon
126
Adobe
ADBE
$99B
$12.5M 0.27%
37,106
-2,314
-6% -$740K
CITE
127
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
$12.4M 0.27%
1,199,068
+694,341
+138% +$7.1M
XC icon
128
WisdomTree True Emerging Markets Fund
XC
$79.9M
$12.3M 0.27%
498,741
+5,472
+1% +$135K
JNPR
129
DELISTED
Juniper Networks
JNPR
$12.3M 0.27%
385,989
-18,201
-5% -$551K
AMZN icon
130
Amazon
AMZN
$2.48T
$12.2M 0.26%
145,677
-161,986
-53% -$16M
LMT icon
131
Lockheed Martin
LMT
$134B
$12.2M 0.26%
25,104
-745
-3% -$346K
FLD
132
Fold Holdings
FLD
$22.9M
$12.2M 0.26%
1,215,651
+321,251
+36% +$3.19M
ABNB icon
133
Airbnb
ABNB
$90.9B
$12.2M 0.26%
142,160
+72,800
+105% +$7.35M
ADM icon
134
Archer Daniels Midland
ADM
$40.1B
$12M 0.26%
128,984
+29,800
+30% +$2.75M
GOOG icon
135
Alphabet (Google) Class C
GOOG
$4.07T
$12M 0.26%
134,906
-1,141
-0.8% -$109K
NBIX icon
136
Neurocrine Biosciences
NBIX
$18.4B
$12M 0.26%
100,105
+6,825
+7% +$799K
VTR icon
137
Ventas
VTR
$47.7B
$11.7M 0.25%
259,742
+1,872
+0.7% +$78.9K
BNY
138
Bank of New York Mellon
BNY
$106B
$11.7M 0.25%
256,915
+5,533
+2% +$237K
BKNG icon
139
Booking.com
BKNG
$154B
$11.6M 0.25%
144,075
-6,200
-4% -$471K
NFG icon
140
National Fuel Gas
NFG
$7.73B
$11.5M 0.25%
182,231
+4,115
+2% +$265K
LYV icon
141
Live Nation Entertainment
LYV
$42.1B
$11.5M 0.25%
164,752
+2,760
+2% +$205K
CBOE icon
142
Cboe Global Markets
CBOE
$31.1B
$11.3M 0.24%
+90,280
New +$11.1M
IDEV icon
143
iShares Core MSCI International Developed Markets ETF
IDEV
$31.3B
$11.2M 0.24%
200,527
-27,865
-12% -$1.5M
TGT icon
144
Target
TGT
$65.5B
$11.2M 0.24%
74,967
+2,002
+3% +$314K
ENPH icon
145
Enphase Energy
ENPH
$4.79B
$11.1M 0.24%
42,000
SLVR
146
DELISTED
SilverSPAC Inc. Class A Ordinary Share
SLVR
$11.1M 0.24%
1,105,834
+610,077
+123% +$6.04M
VGIT icon
147
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.8B
$11.1M 0.24%
189,798
-4,036
-2% -$236K
OGN icon
148
Organon & Co
OGN
$3.55B
$10.9M 0.23%
388,871
+5,615
+1% +$144K
INTC icon
149
Intel
INTC
$435B
$10.8M 0.23%
409,660
-45,573
-10% -$1.27M
ACN icon
150
Accenture
ACN
$101B
$10.8M 0.23%
40,303

Similar funds

Cantor Fitzgerald's Q4 2022 Portfolio in Review

As of Q4 2022, Cantor Fitzgerald held 934 positions worth $4.65B, up 1.6% from $4.58B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Cantor Fitzgerald deployed $759M of net new capital in Q4 2022, opening 146 new positions and adding to 191 existing holdings. Its largest new stake was TortoiseEcofin Acquisition Corp. III: 2,504,271 shares worth $24.9M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Tesla, an estimated $42.6M trimmed.

  • Cantor Fitzgerald's largest Q4 2022 buy was TortoiseEcofin Acquisition Corp. III: 2,504,271 shares worth $24.9M.
  • Cantor Fitzgerald added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $900M increase.
  • Cantor Fitzgerald's biggest Q4 2022 reduction was Tesla, cutting an estimated $42.6M.
  • Cantor Fitzgerald fully exited DXC Technology in Q4 2022, selling an estimated $30.7M.
  • Cantor Fitzgerald's ten largest holdings make up 14% of its $4.65B portfolio in Q4 2022.
  • Cantor Fitzgerald opened 146 new positions and closed 213 in Q4 2022.
  • Cantor Fitzgerald's portfolio value rose 1.6% quarter-over-quarter to $4.65B.

Based on Cantor Fitzgerald's 13F filing for Q4 2022, filed 14 Feb 2023.